Seres Therapeutics Inc MCRB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
1.02UNCH (UNCH)
Volume
41,660
Close
1.02quote price arrow down-0.01 (-0.97%)
Volume
3,588,332
52 week range
0.54 - 6.26
Loading...
  • Open1.06
  • Day High1.08
  • Day Low0.96
  • Prev Close1.03
  • 52 Week High6.26
  • 52 Week High Date06/14/23
  • 52 Week Low0.54
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap154.03M
  • Shares Out151.01M
  • 10 Day Average Volume8.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.95
  • YTD % Change-27.14

KEY STATS

  • Open1.06
  • Day High1.08
  • Day Low0.96
  • Prev Close1.03
  • 52 Week High6.26
  • 52 Week High Date06/14/23
  • 52 Week Low0.54
  • 52 Week Low Date04/19/24
  • Market Cap154.03M
  • Shares Out151.01M
  • 10 Day Average Volume8.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.95
  • YTD % Change-27.14

RATIOS/PROFITABILITY

  • EPS (TTM)-0.61
  • P/E (TTM)-1.68
  • Fwd P/E (NTM)-0.91
  • EBITDA (TTM)-67.032M
  • ROE (TTM)-538.57%
  • Revenue (TTM)126.847M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-65.18%
  • Debt To Equity (MRQ)-170.76%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Seres Therapeutics Inc

 

Profile

MORE
Seres Therapeutics, Inc. is a commercial-stage microbiome therapeutics company. It is focused on the development and commercialization of a novel class of biological drugs, which are designed to treat disease by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. Its lead program, VOWST, is to prevent recurrence of Clostridioides difficile infection (CDI) in patients 18 or older following antibacterial...
Stephen Berenson
Independent Chairman of the Board
Eric Shaff
President, Chief Executive Officer, Director
Marella Thorell
Chief Financial Officer, Executive Vice President
Matthew Henn Ph.D.
Executive Vice President, Chief Scientific Officer
Lisa von Moltke M.D.
Executive Vice President, Chief Medical Officer
Address
101 Cambridge Park Drive
Cambridge, MA
02140
United States

Top Peers

SYMBOLLASTCHG%CHG
RIGL
Rigel Pharmaceuticals Inc
0.9844-0.0356-3.4902%
HBIO
Harvard Bioscience Inc
3.53-0.03-0.84%
KPTI
Karyopharm Therapeutics Inc
1.09+0.02+1.87%
CTMX
CytomX Therapeutics Inc
1.98-0.06-2.94%
RPTX
Repare Therapeutics Inc
3.50-0.14-3.85%